Citanest Forte is a Submucosal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Dentsply Pharmaceutical Inc.. The primary component is Prilocaine Hydrochloride; Epinephrine Bitartrate.
| Product ID | 66312-540_5bc16e4b-6878-839f-e053-2991aa0abf4a |
| NDC | 66312-540 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Citanest Forte |
| Generic Name | Prilocaine Hydrochloride And Epinephrine Bitartrate |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBMUCOSAL |
| Marketing Start Date | 1965-11-18 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021383 |
| Labeler Name | Dentsply Pharmaceutical Inc. |
| Substance Name | PRILOCAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
| Active Ingredient Strength | 40 mg/mL; mg/mL |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1965-11-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021383 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1965-11-18 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021383 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1965-11-18 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PRILOCAINE HYDROCHLORIDE | 40 mg/mL |
| SPL SET ID: | a654df2a-68bc-43c5-bd97-ad43f8679dc0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |